Candace S. Johnson, PhD, President & CEO and Wallace Family Chair in Translational Research at Roswell Park Comprehensive Cancer Center, was recognized as the 2015 honoree at the American Cancer Society’s (ACS) Cuisine for a Cure gala, held on Saturday, Sept. 19 at Statler City.

Candace Johnson, PhD, President and CEO of Roswell Park Cancer Institute is elected to the Board of Directors of the Association of American Cancer Institutes, effective at the national organization’s annual meeting to be held in Washington, D.C. on Sunday, October 25.

Philip L. McCarthy, MD, Professor of Oncology and Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, was welcomed as a Managing Myeloma world expert to present “Selecting Patients for Maintenance or Continuous Therapy Including Regimen Selection and Duration of Treatment.”

Roswell Park Cancer Institute faculty member and researcher Rodney Haring, PhD, MSW, will present his research, “Adapting assessment tools to measure obesity and cancer prevention: diet, physical activity, workplace productivity, and cancer knowledge” during a webinar hosted by the AcademyHealth/Aetna Foundation Scholars in Residence Fellowship Program.

Significant differences in attitudes toward smoking cessation are reported between two generations of smokers in Northern Appalachia in new research from Roswell Park Cancer Institute.

An innovative vaccine therapy developed at Roswell Park Cancer Institute is being tested in a multisite clinical trial involving 50 patients with newly diagnosed glioblastoma brain tumors. The phase II study, now accruing patients at both Roswell Park and the Cleveland Clinic, will assess the effectiveness of the SurVaxM vaccine in combination with standard chemotherapy as treatment for this often-fatal cancer.